Yahoo Finance La Jolla Pharmaceutical (LJPC) Jumps: Stock Gains 5.8%
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 25.1% since Nov 17, 2014.
The company has seen no estimate revisions in the past 7 days and the Zacks Consensus Estimate has also remained unchanged over the same time frame. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
La Jolla Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked biotechnology stocks include AcelRx Pharmaceuticals, Inc. (ACRX), Lannett Company, Inc. (LCI) and IGI, Laboratories, Inc. (IG). Each of these stocks sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
LA JOLLA PHARMACEUTICAL CO (LJPC): Free Stock Analysis Report
ACELRX PHARMACEUTICALS INC (ACRX): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
IGI LABORATORIES INC (IG): Free Stock Analysis Report
Zacks Investment Research
